Open Orphan plc (LON:ORPH)’s stock price fell 1.9% during mid-day trading on Thursday . The stock traded as low as GBX 19.50 ($0.26) and last traded at GBX 19.88 ($0.27). 1,146,496 shares changed hands during mid-day trading, a decline of 35% from the average session volume of 1,767,422 shares. The stock had previously closed at GBX 20.25 ($0.27).
The firm has a market cap of £137.54 million and a P/E ratio of -41.00. The company has a quick ratio of 1.26, a current ratio of 1.30 and a debt-to-equity ratio of 11.66. The business has a fifty day moving average of GBX 20.85 and a 200 day moving average of GBX 23.09.
Open Orphan Company Profile (LON:ORPH)
Open Orphan plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to Big Pharma, biotech, government, and public health organizations. The company has a portfolio of eight human challenge study models for conditions, such as RSV, flu, asthma and COPD, as well as developing COVID-19 human challenge study model.
Further Reading: The mechanics of the bid-ask spread in trading
Receive News & Ratings for Open Orphan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Open Orphan and related companies with MarketBeat.com's FREE daily email newsletter.